If you are interested, please contact us.
As scientists race to test coronavirus vaccines in humans, a parallel scramble is underway to produce billions of medical-grade vials and syringes that will be needed to inoculate the world’s population.
The job of delivering a vaccine to a majority of humans is so vast that global production of pharmaceutical vials needs to be ramped up by 5 to 10 percent within two years, a job the industry says requires immediate preparation and increases in production but is not an insurmountable challenge.
To get to “herd immunity,” the threshold where the coronavirus is no longer able to easily spread, as many as 5.6 billion of the world’s 8 billion people will need to receive a vaccine. To be effective, a second booster shot a month or so later is likely to be needed for many of the vaccines under development. That means more than 11 billion individual doses may be needed to defeat the virus.
(Quzhou Lab Technology Co.,Ltd offer 10ml vaccine vials for vaccine research.)
The demand for vials has already begun because of the scientific community’s speedy response to develop vaccines. Drugmakers including Johnson & Johnson, AstraZeneca, Merck, Moderna and Novavax — to name five that the Trump administration’s Operation Warp Speed is supporting — are preparing to manufacture vaccine in large quantities and fill vials for shipping without even knowing whether their vaccines are effective.
For coronavirus, the industry is settling on 10-milliliter vials, capable of holding eight to 15 doses, as the most common standard.
This is an article about Small Glass Vaccine Vials to deliver coronavirus vaccine around the world. If you are interested, please contact us.